Ji‐Chao Zhou

516 total citations
15 papers, 381 citations indexed

About

Ji‐Chao Zhou is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ji‐Chao Zhou has authored 15 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ji‐Chao Zhou's work include Bioactive natural compounds (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Ji‐Chao Zhou is often cited by papers focused on Bioactive natural compounds (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Ji‐Chao Zhou collaborates with scholars based in China and Hong Kong. Ji‐Chao Zhou's co-authors include Xiaowei Zhang, Xiaowei Zhang, Zhuowei Hu, Bing Cui, Xiaoxi Lv, Fang Hua, Jiaojiao Yu, Dian Peng, Ke Li and Jinmei Yu and has published in prestigious journals such as Nature Communications, Autophagy and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Ji‐Chao Zhou

15 papers receiving 380 citations

Peers

Ji‐Chao Zhou

EPIDE

HEPAT

IMMUN

CCM

Clare A. Balendran Sweden

Wenjun Du China

Prachi Hote United States

Christophe Empsen Belgium

Han Guo China

Natsuko Hada Japan

Seung‐Jin Kim United States

Luis Leiva‐Vega Spain

Seol Hee Park United States

Yeni Ait Ahmed United States

Clare A. Balendran Sweden

Ji‐Chao Zhou

111 ×0.6

157 ×1.2

EPIDE

53 ×0.8

HEPAT

85 ×1.5

IMMUN

25 ×0.5

CCM

Citations per year, relative to Ji‐Chao Zhou Ji‐Chao Zhou (= 1×) peers Clare A. Balendran

Countries citing papers authored by Ji‐Chao Zhou

Since Specialization

Citations

This map shows the geographic impact of Ji‐Chao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Chao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Chao Zhou more than expected).

Fields of papers citing papers by Ji‐Chao Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Chao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Chao Zhou. The network helps show where Ji‐Chao Zhou may publish in the future.

Co-authorship network of co-authors of Ji‐Chao Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Chao Zhou. A scholar is included among the top collaborators of Ji‐Chao Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Chao Zhou. Ji‐Chao Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhou, Ji‐Chao, Huanhuan Gao, Wenjie Qin, et al.. (2024). Heteryunine A, an amidated tryptophan-catechin-spiroketal hybrid with antifibrotic activity from Heterosmilax yunnanensis. Bioorganic Chemistry. 151. 107618–107618. 3 indexed citations

Wang, Feng, Yunxuan Li, Zhao-na Yang, et al.. (2024). Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nature Communications. 15(1). 203–203. 8 indexed citations

Zhou, Ji‐Chao, Yuanyuan Liu, Xiaoli Wei, et al.. (2024). Glycnsisitin A: A promising bicyclic peptide against heart failure that facilitates TFRC-mediated uptake of iron in cardiomyocytes. Acta Pharmaceutica Sinica B. 14(7). 3125–3139. 5 indexed citations

Yu, Jiaojiao, Yuzhen Gao, Shan Chang, et al.. (2024). PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability. Acta Pharmaceutica Sinica B. 14(10). 4378–4395. 6 indexed citations

Zhou, Ji‐Chao, Wenjie Qin, Xiumei Duan, et al.. (2024). Fourteen new 2-benzylbenzofuran glycosides with cardioprotective activity from Heterosmilax yunnanensis. Bioorganic Chemistry. 143. 107079–107079. 3 indexed citations

Zhou, Ji‐Chao, Ruoyu Wang, Zhimeng Zhang, et al.. (2023). Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy. Frontiers in Pharmacology. 14. 1118017–1118017. 23 indexed citations

Xu, Anjian, Ji‐Chao Zhou, Yanmeng Li, et al.. (2021). 14-kDa phosphohistidine phosphatase is a potential therapeutic target for liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 320(3). G351–G365. 5 indexed citations

Zhou, Ji‐Chao & Xiaowei Zhang. (2019). Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases. Chinese Journal of Natural Medicines. 17(11). 835–841. 41 indexed citations

Zhang, Xiaowei, Ji‐Chao Zhou, Dian Peng, et al.. (2019). Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy. 16(5). 782–796. 132 indexed citations

10.

Liu, Peng, Ji‐Chao Zhou, Fang Hua, et al.. (2019). Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin‐Induced Heart Failure Through Resolution of Toll‐Like Receptor 2–Mediated Myocardial Inflammation. Journal of the American Heart Association. 8(20). e012338–e012338. 43 indexed citations

11.

Wu, Rina, Tianyu Yu, Ji‐Chao Zhou, et al.. (2018). Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts. International Journal of Cardiology. 267. 156–162. 43 indexed citations

12.

Jin, Wen, Bing Cui, Pingping Li, et al.. (2018). 1,25-Dihydroxyvitamin D3 protects obese rats from metabolic syndrome via promoting regulatory T cell-mediated resolution of inflammation. Acta Pharmaceutica Sinica B. 8(2). 178–187. 21 indexed citations

13.

Zhou, Ji‐Chao, et al.. (2017). Effect of Xiaoqinglong decoction on mucus hypersecretion in the airways and cilia function in a murine model of asthma. Journal of Traditional Chinese Medical Sciences. 4(3). 290–296. 3 indexed citations

14.

Zhang, Xiaowei, Ji‐Chao Zhou, & Zhuowei Hu. (2017). Autophagy as a target for development of anti-diabetes drugs derived from natural compounds. Journal of Asian Natural Products Research. 19(4). 314–319. 3 indexed citations

15.

Zhang, Xiaowei, Su Mi, Zhe Li, et al.. (2016). Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes. Oncotarget. 8(6). 9922–9934. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact